ORBIMED ADVISORS LLC 13D and 13G filings for NeuroPace, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:35 pm Sale | 2026-03-31 | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 2,096,527 6.200% | -517,657 (-19.80%) | Filing |
| 2025-08-14 6:03 pm Sale | 2025-06-30 | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 2,614,184 8.000% | -792,151 (-23.26%) | Filing |
| 2025-05-15 8:15 pm Unchanged | 2025-03-31 | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 3,406,335 10.500% | 0 (Unchanged) | Filing |
| 2024-11-14 6:30 pm Sale | 2024-09-30 | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 3,406,335 11.700% | -597,632 (-14.93%) | Filing |
| 2024-02-14 7:00 pm Sale | 2023-12-31 | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 4,003,967 15.200% | -8,314 (-0.21%) | Filing |
| 2023-02-14 4:48 pm Unchanged | 2022-12-31 | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 4,012,281 16.100% | 0 (Unchanged) | Filing |
| 2022-02-11 4:35 pm Unchanged | 2021-12-31 | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 4,012,281 16.500% | 0 (Unchanged) | Filing |